11 September 2023 - NICE has issued final draft guidance recommending UCB's Bimzelx (bimekizumab), with the inflammatory disease drug now ...
12 September 2023 - In 2022, NICE introduced the first phase of a new proportionate approach to technology appraisals. ...
8 September 2023 - Around 180,000 people with difficult to manage type 2 diabetes could benefit from a new treatment ...
6 September 2023 - NICE has published final evidence-based recommendations on the use of mavacamten (Camzyos) for the treatment of ...
4 September 2023 - NICE has recommended Chiesi’s Elfabrio (pegunigalsidase alfa) as a long-term option for treating Fabry disease in ...
1 September 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
23 August 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
18 August 2023 - Around 670 people in England with painful and debilitating skin wounds caused by a rare inherited disorder ...
17 August 2023 - The UK's cost effectiveness agency NICE has recommended MSD's PD-1 inhibitor Keytruda for a series of ...
15 August 2023 - NICE has published evidence-based recommendations on the use of cipaglucosidase alfa (Pombiliti) with miglustat (Opfolda) for ...
1 August 2023 - Local GP leaders across the south of England have told practices not to follow the NHS’s ...
3 August 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
2 August 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
2 August 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
1 August 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...